Neoplastic meningitis-related encephalopathy

Journal of Neuro-Oncology

Volumn 72, Issue 2, 2005, Pages 185-189

  Chamberlain, Marc C ^a   Tsao Wei, Denice ^b   Groshen, Susan ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Encephalopathy; Neoplastic meningitis

Indexed keywords

CORTICOSTEROID; CYTARABINE; METHOTREXATE; THIOTEPA;

ADULT; AGE; AGED; ARTICLE; ASEPTIC MENINGITIS; BRAIN DISEASE; BREAST CANCER; CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CATHETER INFECTION; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COHORT ANALYSIS; COLORECTAL CANCER; CONFUSION; CONTROLLED STUDY; CRANIAL NEUROPATHY; CYTOLOGY; DRUG FATALITY; DRUG INDUCED HEADACHE; FEBRILE NEUTROPENIA; FEMALE; FEVER; HISTOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; MELANOMA; MENINGITIS; NAUSEA AND VOMITING; NEURORADIOLOGY; NEUTROPENIA; NONHODGKIN LYMPHOMA; PATIENT CARE; PERFORMANCE; PHOTOPHOBIA; PREDICTION; PROSTATE CANCER; SPINAL CORD DISEASE; SURVIVAL TIME; THROMBOCYTOPENIA;

ADULT; AGED; BRAIN NEOPLASMS; CONFUSION; FEMALE; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MENINGITIS; MIDDLE AGED; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 20444430861     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11060-004-2062-y     Document Type: Article

References (14)

1. MJ Glantz KA Jaeckle MC Chamberlain et al. 1999 A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors Clin Cancer Res 5 11 3394-3402 1:CAS:528:DyaK1MXotV2gsL0%3D 10589750
2. MJ Glantz S LaFollette KA Jaeckle W Shapiro L Swinnen et al. 1999 Randomized trial of a slow release versus a standard formulation of cytarabine for the Intrathecal treatment of lymphomatous meningitis J Clin Oncol 17 3110-3116 1:CAS:528:DyaK1MXmslGmtL8%3D 10506606
3. KA Jaeckle T Batchelor SJ O'Day S Phuphanich P New et al. 2002 An open trial of sustained-release cytarabine (Depocyt) for the intrathecal treatment of solid tumor neoplastic meningitis J Neuro-Oncol 57 3 231-239 10.1023/A:1015752331041
4. 111Indium-DTPA CSF flow studies in leptomeningeal metastases Neurology 46 1674-1677 1:STN:280:BymB2cfpvVM%3D 8649568
5. MC Chamberlain L Dirr 1993 Involved field radiotherapy and intra-ommaya methotrexate/ara-C in patients with AIDS-related lymphomatous meningitis J Clin Oncol 11 1978-1993 1:STN:280:ByuD3MritFw%3D 7692000
6. MC Chamberlain 1995 Comparative spine imaging in leptomeningeal metastases J Neuro Oncol 23 233-238 10.1007/BF01059954 1:STN:280:ByqH3cvislc%3D
7. MC Chamberlain A Sandy GA Press 1990 Leptomeningeal metastasis: A comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain Neurology 40 435-438 1:STN:280:By%2BC1M7htl0%3D 2314584
8. M Glantz WA Hall BF Cole et al. 1995 Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow studies Cancer 75 2919-2931 1:STN:280:ByqB1M3is1M%3D 7773943
9. RJ Freilich G Krol LM DeAngelis 1995 Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis Ann Neurol 38 51-57 10.1002/ana.410380111 1:STN:280:ByqA3snhsFY%3D 7611725
10. Log rank test (2×K tables): Miller RG, Jr: Survival Analysis. John Wiley & Sons, New York, pp 114-118, 1981
11. SAS Version 8, Cary, NC: SAS Institute Inc., 1999
12. Epilog Window: Epicenter Software, 1999, Pasadena, CA
13. M Balm J Hammack 1996 Leptomeningeal Carcinomatosis: Presenting Features and Prognostic Factors Arch Neurol 53 626-632 1:STN:280:BymB2s7jtlE%3D 8929170
14. AM Sherman K Jaeckle CA Meyers 2002 Pretreatment cognitive performance predicts survival in patients with leptomeningeal disease Cancer 95 6 1311-1316 10.1002/cncr.10816 12216100